Tourist's life-changing injuries after swimming in filthy hotel pool and contracting horrific infection
Alexis Williams, 23, was staying at the Residence Inn Downtown Ann Arbor Hotel in Michigan in June while visiting her grandmother, who was having a procedure at a nearby medical center.
She decided to take a swim in the hotel's pool with her cousins, who soon became violently ill and started vomiting.
Williams scraped her knee while she was swimming and contracted a rare infection called MRSA, or Methicillin-resistant Staphylococcus aureus.
MRSA is caused by staph bacteria and is resistant to most antibiotics, according to the Centers for Disease Control and Prevention.
Within hours of swimming in the pool, Williams was overcome with severe pain and couldn't even walk, she recalled to local news.
'It was outrageous,' she told local Fox affiliate, Fox 2 Detroit.
'The pain was excruciating. I had to get poked a lot with a whole bunch of needles, and being prescribed medications I never thought I'd be prescribed to.'
Williams told local news that doctors said they may have to amputate her leg if they can't get the infection under control
Williams had three surgeries on her leg and remains on strong IV antibiotics, according to her lawyer, Ven Johnson.
She now has to constantly receive medication through intravenous therapy and needs a walker. Williams even feared that her leg would have to be amputated.
'I've gone through a lot of pain and suffering, and still currently am,' she told the Detroit Free Press.
'I'm very frightened, very nervous and just appalled by everything.'
Williams' lawyers obtained records from the Michigan Department of Environment, Great Lakes, and Energy that revealed the heinous conditions of the hotel's pool.
Her lawyers said inspections of the swimming pool on June 12, June 27, and July 8 showed no chlorine or bromine in the water.
The civil complaint argues that 'the hotel knew that its swimming pool had a Standard Plate Count that exceeded 200 CFU/ml, which indicates a dangerous level of bacteria present in the swimming pool and poor disinfection.'
Williams' lawyers believe that the hotel knew the pool didn't have these chemicals and had improper pH levels.
Her legal team accused the hotel of disregarding public safety and creating an unsafe environment for guests.
'Alexis started developing this infection within several hours of coming into contact with this water,' Michael Freifeld, an attorney with Williams' legal team, told the Detroit Free Press.
Williams' legal team alleges that the hotel's pool didn't have chlorine or bromine in the water, creating an unsafe situation for guests
'We have no doubt, given the records we have and the experts that we are going to hire, that the infection Alexis experienced, and is experiencing, was clearly connected to the pool.'
Johnson added that Williams still has a long way ahead of her, and doctors said they may have to amputate if the infection isn't under control.
'For anybody, let alone a 23-year-old young person, it's a very scary, uncertain prognosis,' Johnson said.
The lawsuit is seeking $25,000 in damages. Daily Mail reached out to First Martin Corporation, which owns the Residence Inn for comment on the accusations.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
20 minutes ago
- The Independent
‘You can literally pregame recess with these': Experts warn of caffeine pouches targeting teens
Last summer, a TikTok user shared a video responding to a commenter asking if 13-year-olds can use caffeine pouches. The pouches, which are placed between your cheeks and gums to absorb the stimulant directly, have become increasingly popular amongst teens. 'Yes, guys, you can literally pregame recess with these,' the video creator says, holding up a tin of LyvWel 'Cherry Blast' caffeine pouches. There are a lot of similar videos all over TikTok. 'Can a 13-year-old use or buy upper-deckies from the TikTok shop? Yeah, of course you can,' a different user said, referencing the popular online nickname for pouch products. 'These are literally just caffeine pouches.' There is no national age restriction on caffeine in the U.S., so anyone can purchase products that contain the stimulant. Caffeine use in kids can even result in a hospital trip, which is rare but on the rise. The number of children ages 11 to 14 who had to visit the emergency room due to a caffeine overdose doubled between 2017 and 2023, according to a November 2024 study. And experts are getting increasingly concerned about the impact of caffeine on children, and the marketing tactics that could expose kids to these products. Dr. Michael Garcia, an internal medicine doctor with a focus on nutrition at UCLA Health, told The Independent that 'less is more' when it comes to caffeine for adolescents. Long-term use among teens can increase blood pressure, worsen anxiety and impact sleep, he explained. 'We know caffeine is one of those things our body can develop tolerance to,' Garcia said. 'So little by little, maybe use increases as that tolerance develops. And it's like any other stimulant or substance that gives us some sort of immediate effect, we then depend on it ... long-term.' The American Academy of Pediatrics suggests 100mg as the upper limit for kids 12-18, which is about the equivalent of a cup of drip coffee, about two cans of Diet Coke, or one energy drink. There are several other companies that sell caffeine pouches, including Deckiez, Rebel Pouches, and Wip, a caffeine pouch start-up founded by Richard Mumby, a strategic investor and marketing executive who worked with the e-cigarette company Juul. Different brands have different amounts of caffeine: many of LyvWel's pouches contain 56mg per pouch, which is roughly equivalent to a can of soda. Deckiez sells pouches with 40mg and 50mg of caffeine. Wip sells products with 100mg and 200mg of caffeine per pouch, with 15 pouches per package. Wip's Instagram features influencers over 18 promoting the products while doing athletic activities, including surfing, skateboarding and weightlifting. Rebel Pouches' Instagram shows men playing golf, softball and running, amongst other sports. Deckiez, founded by a teenager and his father, shows the now-college student founder talking with other young men, and shows people snowboarding and playing softball. LyvWel's focuses on discount prices and flavor variety. Dr. Robert Jackler, founder of the Stanford Research Into the Impact of Tobacco Advertising group, tells The Independent he's concerned social media marketing tactics could make teens eager to try the products, pointing out Wip's use of sports teens are particularly attracted to. 'These videos of the skateboarder doing his tricks…I mean, there may be 50-year-olds and 30-year-olds who are interested in that, but it clearly has a differential interest amongst young people,' he said. Dr. Bonnie Halpern-Felsher, a developmental psychologist at Stanford Medicine, also argued that using influencers and sporty imagery indicates it's 'clearly being marketed to young people.' 'You could talk about users on the way to the office, on the way to a business meeting…that would be much more obvious that you're targeting adults,' she said. 'There's nothing that I can see of the sort here. It is all fun and games.' However, caffeine pouch companies claim that they only aim their products to over-18s and, there's age-related warnings on the tin. Wip rejects any suggestion that they have advertised to underage children, with the company noting that its packaging is designed to appeal to adults and that hiring influencers is normal marketing practice. The product also includes age and usage recommendations, including a warning that says Wip is intended for people 18 and older. 'Wip has adopted an exceptionally proactive and responsible marketing approach, grounded in and exceeding official health authority guidelines,' the company said in a statement to The Independent. Deckiez founders Dean and Mike Herkenrath noted that their product was created 'as a healthier alternative to the huge spike in nicotine pouch use' and pointed out that caffeine has some health benefits for adults. For instance, studies have shown that adult coffee drinkers are less likely to develop heart failure, according to Johns Hopkins Medicine. 'Many of our customers have quit or heavily reduced their nicotine pouch consumption and we're very proud of that,' the Herkenraths said in a statement. 'Our social media content is indented for success minded young adults to ageless at heart seeking to energize their goals!' LyvWel said in a statement to The Independent that the TikTok creators encouraging 13-year-olds to try their caffeine pouches are not affiliated with the company, and appear to be using 'TikTok's Affiliate Program, which allows any user regardless of age to tag and promote TikTok shop products without brand involvement or approval.' The company says it has tried to report 'several inappropriate videos,' but some haven't been taken down. The Independent has contacted TikTok for comment. As interest in caffeine pouches grows, Dr. Grace Kong, a psychiatry professor at Yale Medicine who specializes in child and adolescent psychology, told The Independent that adolescents don't have all the tools they need to make informed decisions about caffeinated products, especially those they find on social media. 'There is an issue if we're targeting that kind of advertising or marketing to teens for those substances, because teens are still minors,' she told The Independent. 'There still needs to be protection in some way about the decision-making.' She noted that she thinks caffeine pouches are too similar in design to nicotine pouches, which could encourage young people to try them. 'It could be a gateway, or it could really normalize pouch use,' Kong said. There's also concern about how the caffeine is being delivered through these pouches, Dr. Taylor Argo, an adolescent medicine fellow at the University of Michigan, told The Independent. 'There are lots of blood vessels right there, and so that caffeine is being absorbed directly into the bloodstream…we hypothesize that when you put medicines directly into your mouth that way, or other substances, it's absorbed a little faster,' she said. The 'biggest risk factor' for teens when using high levels of caffeine is irregular heart rates, also known as cardiac arrhythmias, Argo said. 'I actually have not heard of any of my patients using these, and I care for teens every day…I do worry about the amount of caffeine that is in it and how it's being delivered,' she added. Garcia encourages parents to talk about caffeine products with their teens and learn why they might want to use them. 'I think as adults, we are always inclined to provide a solution, but I think there's a lot of value in listening,' he said.
Daily Mail
20 minutes ago
- Daily Mail
FDA escalates butter recall over undeclared allergen
By The FDA has escalated its warning over a major butter recall that was triggered by a labeling issue. Bunge North America recalled 64,800 lbs of its Non-Hydrogenated European Style Butter Blend last month after investigators found the label did not include milk in the ingredient list. But now the FDA has upgraded the alert to Class II, used when officials fear temporary or medically reversible health effects. Up to 50million Americans are lactose intolerant, estimates suggest, while 6.1million have an allergy to milk. A milk allergy can result in hives, a rash, vomiting, diarrhea, abdominal pain, trouble breathing or a life-threatening reaction called anaphylaxis. The butters were distributed to restaurants and bakeries across the US and the Dominican Republic. They were not sold in grocery stores. The recall included 1,800 cases of 36-count 1lbs butter blocks. A total of 64,800 blocks of the butter have been recalled. The FDA said butters in the recall had a product code found on their packaging that reads: 5064036503. It has not been revealed whether there are any reports of adverse reactions as a result of consuming the butter. Businesses that received the butter were warned over the labeling issue via email, letter, telephone call or a visit . Estimates suggest about 30 to 50million Americans suffer from lactose intolerance, leaving them unable to eat foods such as butter. The condition is caused by the small intestine no longer making the enzyme lactase, which is used to break down the sugar lactose found in milk-containing foods. It can cause stomach upset and bloating but it is not a life threatening allergy. It more commonly affects African or Hispanic Americans and people who have taken antibiotics or chemotherapy drugs. Doctors say the condition usually can't be reversed, and people are advised to manage it by following a low-lactose diet. This is done by limiting consumption of any lactose-containing foods, such as cakes, cookie dough and milk chocolate. People with a milk allergy, however, can suffer more severe symptoms within minutes of consuming cow's milk. It is caused by the immune system attacking a protein found in the milk. Those who suffer from the reaction can be treated with antihistamines or epinephrine to reduce the reaction.
Reuters
21 minutes ago
- Reuters
Wegovy maker Novo hit with investor class action over revenue forecast cut
Aug 4 (Reuters) - Novo Nordisk ( opens new tab, maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish pharmaceutical giant misled them with optimistic growth forecasts and minimized competition risks in the obesity market. The proposed class action lawsuit, opens new tab was filed on Friday in the federal court in New Jersey following a sharp decline in the company's stock price. Investors knocked $70 billion off Novo Nordisk's market value on a single trading day last week. Novo last week in a statement said it was lowering its 2025 sales and operating profit outlook due to lower growth expectations in the second half in the United States for Wegovy in the obesity market and the drugmaker's Ozempic in the diabetes market. Novo said its updated sales outlook for Wegovy stemmed from the 'persistent' use of compounded versions of the drug, competition and what it described as slower-than-expected market expansion. A representative from Novo and an attorney for the plaintiff did not immediately respond to requests for comment on Monday about the investor lawsuit. The lawsuit was filed on behalf of potentially thousands of investors who purchased Novo's stock between May 7, 2025 and July 28. The tight supply of Wegovy in the United States in 2022 prompted U.S. regulators to temporarily allow the sale of cheaper, compounded versions of the drug, known chemically as semaglutide. The U.S. Food and Drug Administration in February removed Wegovy from the agency's shortage list. Novo in June said it was ending a partnership with telehealth company Hims & Hers that began in late April, citing Hims' alleged improper marketing and sales of Wegovy copies. Novo accused Hims of 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.' Hims CEO Andrew Dudum in a response accused Novo management of misleading the public and making anticompetitive demands. The case is Eric Barta v. Novo Nordisk et al, U.S. District Court, District of New Jersey, No. 2:25-cv-14045. For plaintiff: Adam Apton of Levi & Korsinsky For defendants: No appearances yet Read more: Novo Nordisk shares dip further as Wegovy gains nearly erased Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership Wegovy maker Novo faces fee demand after losing copycat drug lawsuit Ozempic copies restricted after US judge denies injunction
